nodes	percent_of_prediction	percent_of_DWPC	metapath
Propofol—UGT1A9—Sorafenib—thyroid cancer	0.156	0.21	CbGbCtD
Propofol—UGT1A1—Sorafenib—thyroid cancer	0.127	0.171	CbGbCtD
Propofol—CYP1B1—Doxorubicin—thyroid cancer	0.0894	0.12	CbGbCtD
Propofol—ALB—Vandetanib—thyroid cancer	0.0801	0.108	CbGbCtD
Propofol—CYP2B6—Sorafenib—thyroid cancer	0.0493	0.0663	CbGbCtD
Propofol—CYP2C8—Sorafenib—thyroid cancer	0.0373	0.0502	CbGbCtD
Propofol—CYP2C19—Sorafenib—thyroid cancer	0.0313	0.0421	CbGbCtD
Propofol—CYP2B6—Doxorubicin—thyroid cancer	0.0299	0.0402	CbGbCtD
Propofol—CYP1A2—Sorafenib—thyroid cancer	0.0289	0.0389	CbGbCtD
Propofol—CYP2C9—Sorafenib—thyroid cancer	0.026	0.035	CbGbCtD
Propofol—CYP3A4—Vandetanib—thyroid cancer	0.0251	0.0338	CbGbCtD
Propofol—CYP2D6—Sorafenib—thyroid cancer	0.0238	0.032	CbGbCtD
Propofol—CYP3A4—Sorafenib—thyroid cancer	0.0151	0.0204	CbGbCtD
Propofol—CYP2D6—Doxorubicin—thyroid cancer	0.0144	0.0194	CbGbCtD
Propofol—CYP3A4—Doxorubicin—thyroid cancer	0.00918	0.0124	CbGbCtD
Propofol—FAAH—saliva-secreting gland—thyroid cancer	0.00184	0.115	CbGeAlD
Propofol—FAAH—trachea—thyroid cancer	0.00142	0.0886	CbGeAlD
Propofol—UGT1A8—head—thyroid cancer	0.00137	0.0855	CbGeAlD
Propofol—FAAH—thyroid gland—thyroid cancer	0.00112	0.0701	CbGeAlD
Propofol—Hypomagnesaemia—Epirubicin—thyroid cancer	0.001	0.00512	CcSEcCtD
Propofol—FAAH—head—thyroid cancer	0.000996	0.0621	CbGeAlD
Propofol—Loss of consciousness—Vandetanib—thyroid cancer	0.000984	0.00501	CcSEcCtD
Propofol—Cough—Vandetanib—thyroid cancer	0.000977	0.00497	CcSEcCtD
Propofol—Convulsion—Vandetanib—thyroid cancer	0.00097	0.00494	CcSEcCtD
Propofol—Hypertension—Vandetanib—thyroid cancer	0.000966	0.00492	CcSEcCtD
Propofol—Chest pain—Vandetanib—thyroid cancer	0.000953	0.00485	CcSEcCtD
Propofol—Acute coronary syndrome—Sorafenib—thyroid cancer	0.000953	0.00485	CcSEcCtD
Propofol—Renal failure—Sorafenib—thyroid cancer	0.00095	0.00484	CcSEcCtD
Propofol—Anxiety—Vandetanib—thyroid cancer	0.00095	0.00484	CcSEcCtD
Propofol—Myocardial infarction—Sorafenib—thyroid cancer	0.000947	0.00482	CcSEcCtD
Propofol—Neuropathy peripheral—Sorafenib—thyroid cancer	0.000947	0.00482	CcSEcCtD
Propofol—Redness—Epirubicin—thyroid cancer	0.000946	0.00482	CcSEcCtD
Propofol—Dry mouth—Vandetanib—thyroid cancer	0.000932	0.00475	CcSEcCtD
Propofol—Hypomagnesaemia—Doxorubicin—thyroid cancer	0.00093	0.00474	CcSEcCtD
Propofol—Hyperventilation—Epirubicin—thyroid cancer	0.000928	0.00472	CcSEcCtD
Propofol—Oedema—Vandetanib—thyroid cancer	0.000914	0.00465	CcSEcCtD
Propofol—Ileus—Epirubicin—thyroid cancer	0.000902	0.00459	CcSEcCtD
Propofol—Thrombosis—Epirubicin—thyroid cancer	0.000902	0.00459	CcSEcCtD
Propofol—Nystagmus—Epirubicin—thyroid cancer	0.000894	0.00455	CcSEcCtD
Propofol—Hyperlipidaemia—Epirubicin—thyroid cancer	0.000886	0.00451	CcSEcCtD
Propofol—Redness—Doxorubicin—thyroid cancer	0.000875	0.00446	CcSEcCtD
Propofol—Haemoglobin—Sorafenib—thyroid cancer	0.000872	0.00444	CcSEcCtD
Propofol—Haemorrhage—Sorafenib—thyroid cancer	0.000867	0.00442	CcSEcCtD
Propofol—Hyperventilation—Doxorubicin—thyroid cancer	0.000858	0.00437	CcSEcCtD
Propofol—Thrombosis—Doxorubicin—thyroid cancer	0.000835	0.00425	CcSEcCtD
Propofol—Ileus—Doxorubicin—thyroid cancer	0.000835	0.00425	CcSEcCtD
Propofol—Musculoskeletal discomfort—Vandetanib—thyroid cancer	0.000832	0.00424	CcSEcCtD
Propofol—Nystagmus—Doxorubicin—thyroid cancer	0.000827	0.00421	CcSEcCtD
Propofol—Amblyopia—Epirubicin—thyroid cancer	0.000827	0.00421	CcSEcCtD
Propofol—Insomnia—Vandetanib—thyroid cancer	0.000826	0.00421	CcSEcCtD
Propofol—Paraesthesia—Vandetanib—thyroid cancer	0.00082	0.00418	CcSEcCtD
Propofol—Hyperlipidaemia—Doxorubicin—thyroid cancer	0.000819	0.00417	CcSEcCtD
Propofol—Dyspnoea—Vandetanib—thyroid cancer	0.000815	0.00415	CcSEcCtD
Propofol—Tinnitus—Sorafenib—thyroid cancer	0.000809	0.00412	CcSEcCtD
Propofol—Flushing—Sorafenib—thyroid cancer	0.000805	0.0041	CcSEcCtD
Propofol—Stinging—Epirubicin—thyroid cancer	0.000788	0.00401	CcSEcCtD
Propofol—Fatigue—Vandetanib—thyroid cancer	0.000788	0.00401	CcSEcCtD
Propofol—Injection site pain—Epirubicin—thyroid cancer	0.000782	0.00398	CcSEcCtD
Propofol—Pain—Vandetanib—thyroid cancer	0.000781	0.00398	CcSEcCtD
Propofol—Arrhythmia—Sorafenib—thyroid cancer	0.000775	0.00395	CcSEcCtD
Propofol—Amblyopia—Doxorubicin—thyroid cancer	0.000765	0.0039	CcSEcCtD
Propofol—Erythema—Sorafenib—thyroid cancer	0.000755	0.00385	CcSEcCtD
Propofol—Delirium—Epirubicin—thyroid cancer	0.000742	0.00378	CcSEcCtD
Propofol—Dysgeusia—Sorafenib—thyroid cancer	0.000739	0.00377	CcSEcCtD
Propofol—Extravasation—Epirubicin—thyroid cancer	0.000732	0.00373	CcSEcCtD
Propofol—SCN4A—thyroid gland—thyroid cancer	0.000729	0.0455	CbGeAlD
Propofol—Stinging—Doxorubicin—thyroid cancer	0.000729	0.00371	CcSEcCtD
Propofol—Muscle spasms—Sorafenib—thyroid cancer	0.000726	0.0037	CcSEcCtD
Propofol—Injection site pain—Doxorubicin—thyroid cancer	0.000723	0.00368	CcSEcCtD
Propofol—Body temperature increased—Vandetanib—thyroid cancer	0.000722	0.00368	CcSEcCtD
Propofol—Abdominal pain—Vandetanib—thyroid cancer	0.000722	0.00368	CcSEcCtD
Propofol—Ventricular extrasystoles—Epirubicin—thyroid cancer	0.000707	0.0036	CcSEcCtD
Propofol—Thinking abnormal—Epirubicin—thyroid cancer	0.000697	0.00355	CcSEcCtD
Propofol—FAAH—lymph node—thyroid cancer	0.000697	0.0435	CbGeAlD
Propofol—Oliguria—Epirubicin—thyroid cancer	0.000693	0.00353	CcSEcCtD
Propofol—Angioedema—Sorafenib—thyroid cancer	0.00069	0.00351	CcSEcCtD
Propofol—Delirium—Doxorubicin—thyroid cancer	0.000687	0.0035	CcSEcCtD
Propofol—Dyskinesia—Epirubicin—thyroid cancer	0.000679	0.00346	CcSEcCtD
Propofol—Syncope—Sorafenib—thyroid cancer	0.000677	0.00345	CcSEcCtD
Propofol—Extravasation—Doxorubicin—thyroid cancer	0.000677	0.00345	CcSEcCtD
Propofol—Creatinine increased—Epirubicin—thyroid cancer	0.000671	0.00342	CcSEcCtD
Propofol—Loss of consciousness—Sorafenib—thyroid cancer	0.000664	0.00338	CcSEcCtD
Propofol—Cough—Sorafenib—thyroid cancer	0.000659	0.00336	CcSEcCtD
Propofol—Atrioventricular block—Epirubicin—thyroid cancer	0.000658	0.00335	CcSEcCtD
Propofol—Asthenia—Vandetanib—thyroid cancer	0.000655	0.00334	CcSEcCtD
Propofol—Ventricular extrasystoles—Doxorubicin—thyroid cancer	0.000654	0.00333	CcSEcCtD
Propofol—Hypertension—Sorafenib—thyroid cancer	0.000652	0.00332	CcSEcCtD
Propofol—SCN4A—head—thyroid cancer	0.000647	0.0404	CbGeAlD
Propofol—Pruritus—Vandetanib—thyroid cancer	0.000646	0.00329	CcSEcCtD
Propofol—Thinking abnormal—Doxorubicin—thyroid cancer	0.000645	0.00329	CcSEcCtD
Propofol—Myalgia—Sorafenib—thyroid cancer	0.000643	0.00327	CcSEcCtD
Propofol—Oliguria—Doxorubicin—thyroid cancer	0.000641	0.00326	CcSEcCtD
Propofol—Hiccups—Epirubicin—thyroid cancer	0.000638	0.00325	CcSEcCtD
Propofol—Ventricular tachycardia—Epirubicin—thyroid cancer	0.000638	0.00325	CcSEcCtD
Propofol—Abnormal dreams—Epirubicin—thyroid cancer	0.000631	0.00321	CcSEcCtD
Propofol—Dry mouth—Sorafenib—thyroid cancer	0.000629	0.0032	CcSEcCtD
Propofol—Dyskinesia—Doxorubicin—thyroid cancer	0.000629	0.0032	CcSEcCtD
Propofol—Hyperkalaemia—Epirubicin—thyroid cancer	0.000627	0.00319	CcSEcCtD
Propofol—Diarrhoea—Vandetanib—thyroid cancer	0.000625	0.00318	CcSEcCtD
Propofol—Creatinine increased—Doxorubicin—thyroid cancer	0.000621	0.00316	CcSEcCtD
Propofol—Salivary hypersecretion—Epirubicin—thyroid cancer	0.00062	0.00316	CcSEcCtD
Propofol—Anaphylactic shock—Sorafenib—thyroid cancer	0.000616	0.00314	CcSEcCtD
Propofol—Atrioventricular block—Doxorubicin—thyroid cancer	0.000609	0.0031	CcSEcCtD
Propofol—Shock—Sorafenib—thyroid cancer	0.000606	0.00309	CcSEcCtD
Propofol—Dizziness—Vandetanib—thyroid cancer	0.000604	0.00308	CcSEcCtD
Propofol—Blood urea increased—Epirubicin—thyroid cancer	0.000603	0.00307	CcSEcCtD
Propofol—Neuropathy—Epirubicin—thyroid cancer	0.000599	0.00305	CcSEcCtD
Propofol—Ventricular tachycardia—Doxorubicin—thyroid cancer	0.000591	0.00301	CcSEcCtD
Propofol—Hiccups—Doxorubicin—thyroid cancer	0.000591	0.00301	CcSEcCtD
Propofol—Abnormal dreams—Doxorubicin—thyroid cancer	0.000584	0.00297	CcSEcCtD
Propofol—Vomiting—Vandetanib—thyroid cancer	0.000581	0.00296	CcSEcCtD
Propofol—Hyperkalaemia—Doxorubicin—thyroid cancer	0.00058	0.00296	CcSEcCtD
Propofol—Rash—Vandetanib—thyroid cancer	0.000576	0.00293	CcSEcCtD
Propofol—Dermatitis—Vandetanib—thyroid cancer	0.000576	0.00293	CcSEcCtD
Propofol—Salivary hypersecretion—Doxorubicin—thyroid cancer	0.000574	0.00292	CcSEcCtD
Propofol—SCN2A—head—thyroid cancer	0.000572	0.0357	CbGeAlD
Propofol—Headache—Vandetanib—thyroid cancer	0.000572	0.00291	CcSEcCtD
Propofol—Pulmonary oedema—Epirubicin—thyroid cancer	0.000568	0.00289	CcSEcCtD
Propofol—Musculoskeletal discomfort—Sorafenib—thyroid cancer	0.000561	0.00286	CcSEcCtD
Propofol—Hypertonia—Epirubicin—thyroid cancer	0.00056	0.00285	CcSEcCtD
Propofol—Blood urea increased—Doxorubicin—thyroid cancer	0.000558	0.00284	CcSEcCtD
Propofol—Abnormal vision—Epirubicin—thyroid cancer	0.000557	0.00284	CcSEcCtD
Propofol—Neuropathy—Doxorubicin—thyroid cancer	0.000555	0.00282	CcSEcCtD
Propofol—Sepsis—Epirubicin—thyroid cancer	0.000554	0.00282	CcSEcCtD
Propofol—Mental disability—Epirubicin—thyroid cancer	0.000554	0.00282	CcSEcCtD
Propofol—Dyspnoea—Sorafenib—thyroid cancer	0.000549	0.0028	CcSEcCtD
Propofol—Nausea—Vandetanib—thyroid cancer	0.000543	0.00276	CcSEcCtD
Propofol—Phlebitis—Epirubicin—thyroid cancer	0.000538	0.00274	CcSEcCtD
Propofol—Fatigue—Sorafenib—thyroid cancer	0.000531	0.00271	CcSEcCtD
Propofol—Pain—Sorafenib—thyroid cancer	0.000527	0.00268	CcSEcCtD
Propofol—Pulmonary oedema—Doxorubicin—thyroid cancer	0.000526	0.00268	CcSEcCtD
Propofol—Hypertonia—Doxorubicin—thyroid cancer	0.000518	0.00264	CcSEcCtD
Propofol—Abnormal vision—Doxorubicin—thyroid cancer	0.000515	0.00262	CcSEcCtD
Propofol—Eye pain—Epirubicin—thyroid cancer	0.000513	0.00261	CcSEcCtD
Propofol—Mental disability—Doxorubicin—thyroid cancer	0.000513	0.00261	CcSEcCtD
Propofol—Sepsis—Doxorubicin—thyroid cancer	0.000513	0.00261	CcSEcCtD
Propofol—Phlebitis—Doxorubicin—thyroid cancer	0.000498	0.00253	CcSEcCtD
Propofol—Urticaria—Sorafenib—thyroid cancer	0.00049	0.00249	CcSEcCtD
Propofol—Body temperature increased—Sorafenib—thyroid cancer	0.000487	0.00248	CcSEcCtD
Propofol—Abdominal pain—Sorafenib—thyroid cancer	0.000487	0.00248	CcSEcCtD
Propofol—GABRB2—head—thyroid cancer	0.000486	0.0304	CbGeAlD
Propofol—GABRG2—head—thyroid cancer	0.000486	0.0304	CbGeAlD
Propofol—Anaphylactoid reaction—Epirubicin—thyroid cancer	0.000479	0.00244	CcSEcCtD
Propofol—Eye pain—Doxorubicin—thyroid cancer	0.000475	0.00242	CcSEcCtD
Propofol—Cardiac failure—Epirubicin—thyroid cancer	0.000475	0.00242	CcSEcCtD
Propofol—Pain in extremity—Epirubicin—thyroid cancer	0.000463	0.00236	CcSEcCtD
Propofol—Diplopia—Epirubicin—thyroid cancer	0.000463	0.00236	CcSEcCtD
Propofol—Affect lability—Epirubicin—thyroid cancer	0.000456	0.00232	CcSEcCtD
Propofol—GABRA2—head—thyroid cancer	0.000444	0.0277	CbGeAlD
Propofol—Anaphylactoid reaction—Doxorubicin—thyroid cancer	0.000443	0.00226	CcSEcCtD
Propofol—Asthenia—Sorafenib—thyroid cancer	0.000442	0.00225	CcSEcCtD
Propofol—Cardiac arrest—Epirubicin—thyroid cancer	0.000441	0.00224	CcSEcCtD
Propofol—Cardiac failure—Doxorubicin—thyroid cancer	0.000439	0.00224	CcSEcCtD
Propofol—Mood swings—Epirubicin—thyroid cancer	0.000439	0.00224	CcSEcCtD
Propofol—Pruritus—Sorafenib—thyroid cancer	0.000436	0.00222	CcSEcCtD
Propofol—Blood creatinine increased—Epirubicin—thyroid cancer	0.000434	0.00221	CcSEcCtD
Propofol—Dehydration—Epirubicin—thyroid cancer	0.000431	0.00219	CcSEcCtD
Propofol—GABRA1—head—thyroid cancer	0.000429	0.0268	CbGeAlD
Propofol—Pain in extremity—Doxorubicin—thyroid cancer	0.000429	0.00218	CcSEcCtD
Propofol—Diplopia—Doxorubicin—thyroid cancer	0.000429	0.00218	CcSEcCtD
Propofol—Affect lability—Doxorubicin—thyroid cancer	0.000422	0.00215	CcSEcCtD
Propofol—Diarrhoea—Sorafenib—thyroid cancer	0.000422	0.00215	CcSEcCtD
Propofol—GABRB3—thyroid gland—thyroid cancer	0.000421	0.0263	CbGeAlD
Propofol—CYP1B1—thyroid gland—thyroid cancer	0.000415	0.0259	CbGeAlD
Propofol—Cardiac arrest—Doxorubicin—thyroid cancer	0.000408	0.00208	CcSEcCtD
Propofol—Dizziness—Sorafenib—thyroid cancer	0.000408	0.00208	CcSEcCtD
Propofol—Mood swings—Doxorubicin—thyroid cancer	0.000406	0.00207	CcSEcCtD
Propofol—Blood creatinine increased—Doxorubicin—thyroid cancer	0.000402	0.00205	CcSEcCtD
Propofol—Dehydration—Doxorubicin—thyroid cancer	0.000399	0.00203	CcSEcCtD
Propofol—Pancreatitis—Epirubicin—thyroid cancer	0.000393	0.002	CcSEcCtD
Propofol—Vomiting—Sorafenib—thyroid cancer	0.000392	0.002	CcSEcCtD
Propofol—Rash—Sorafenib—thyroid cancer	0.000389	0.00198	CcSEcCtD
Propofol—Dermatitis—Sorafenib—thyroid cancer	0.000388	0.00198	CcSEcCtD
Propofol—Headache—Sorafenib—thyroid cancer	0.000386	0.00197	CcSEcCtD
Propofol—GABRB3—head—thyroid cancer	0.000373	0.0233	CbGeAlD
Propofol—CYP1A1—trachea—thyroid cancer	0.000371	0.0232	CbGeAlD
Propofol—CYP1B1—head—thyroid cancer	0.000369	0.023	CbGeAlD
Propofol—Nausea—Sorafenib—thyroid cancer	0.000366	0.00186	CcSEcCtD
Propofol—Pancreatitis—Doxorubicin—thyroid cancer	0.000363	0.00185	CcSEcCtD
Propofol—Hyperglycaemia—Epirubicin—thyroid cancer	0.000361	0.00184	CcSEcCtD
Propofol—Renal failure—Epirubicin—thyroid cancer	0.000351	0.00179	CcSEcCtD
Propofol—Neuropathy peripheral—Epirubicin—thyroid cancer	0.00035	0.00178	CcSEcCtD
Propofol—Hyperglycaemia—Doxorubicin—thyroid cancer	0.000334	0.0017	CcSEcCtD
Propofol—Bradycardia—Epirubicin—thyroid cancer	0.000326	0.00166	CcSEcCtD
Propofol—Renal failure—Doxorubicin—thyroid cancer	0.000325	0.00165	CcSEcCtD
Propofol—Neuropathy peripheral—Doxorubicin—thyroid cancer	0.000324	0.00165	CcSEcCtD
Propofol—Haemoglobin—Epirubicin—thyroid cancer	0.000322	0.00164	CcSEcCtD
Propofol—Haemorrhage—Epirubicin—thyroid cancer	0.000321	0.00163	CcSEcCtD
Propofol—Pharyngitis—Epirubicin—thyroid cancer	0.000318	0.00162	CcSEcCtD
Propofol—GABRA2—lymph node—thyroid cancer	0.000311	0.0194	CbGeAlD
Propofol—Visual impairment—Epirubicin—thyroid cancer	0.000309	0.00157	CcSEcCtD
Propofol—Bradycardia—Doxorubicin—thyroid cancer	0.000302	0.00154	CcSEcCtD
Propofol—Tinnitus—Epirubicin—thyroid cancer	0.000299	0.00152	CcSEcCtD
Propofol—Haemoglobin—Doxorubicin—thyroid cancer	0.000298	0.00152	CcSEcCtD
Propofol—CYP1A2—thyroid gland—thyroid cancer	0.000298	0.0186	CbGeAlD
Propofol—Flushing—Epirubicin—thyroid cancer	0.000298	0.00152	CcSEcCtD
Propofol—Haemorrhage—Doxorubicin—thyroid cancer	0.000297	0.00151	CcSEcCtD
Propofol—Pharyngitis—Doxorubicin—thyroid cancer	0.000294	0.0015	CcSEcCtD
Propofol—CYP1A1—thyroid gland—thyroid cancer	0.000294	0.0183	CbGeAlD
Propofol—Chills—Epirubicin—thyroid cancer	0.000288	0.00146	CcSEcCtD
Propofol—Arrhythmia—Epirubicin—thyroid cancer	0.000286	0.00146	CcSEcCtD
Propofol—Visual impairment—Doxorubicin—thyroid cancer	0.000286	0.00146	CcSEcCtD
Propofol—ALB—lymph node—thyroid cancer	0.000281	0.0176	CbGeAlD
Propofol—Erythema—Epirubicin—thyroid cancer	0.000279	0.00142	CcSEcCtD
Propofol—Tinnitus—Doxorubicin—thyroid cancer	0.000277	0.00141	CcSEcCtD
Propofol—Flushing—Doxorubicin—thyroid cancer	0.000275	0.0014	CcSEcCtD
Propofol—Dysgeusia—Epirubicin—thyroid cancer	0.000273	0.00139	CcSEcCtD
Propofol—Muscle spasms—Epirubicin—thyroid cancer	0.000268	0.00137	CcSEcCtD
Propofol—CYP2E1—thyroid gland—thyroid cancer	0.000268	0.0167	CbGeAlD
Propofol—Chills—Doxorubicin—thyroid cancer	0.000266	0.00136	CcSEcCtD
Propofol—Arrhythmia—Doxorubicin—thyroid cancer	0.000265	0.00135	CcSEcCtD
Propofol—CYP1A1—head—thyroid cancer	0.000261	0.0163	CbGeAlD
Propofol—Erythema—Doxorubicin—thyroid cancer	0.000258	0.00131	CcSEcCtD
Propofol—CYP1B1—lymph node—thyroid cancer	0.000258	0.0161	CbGeAlD
Propofol—Agitation—Epirubicin—thyroid cancer	0.000256	0.00131	CcSEcCtD
Propofol—CYP2B6—head—thyroid cancer	0.000253	0.0158	CbGeAlD
Propofol—Dysgeusia—Doxorubicin—thyroid cancer	0.000253	0.00129	CcSEcCtD
Propofol—Syncope—Epirubicin—thyroid cancer	0.00025	0.00127	CcSEcCtD
Propofol—Muscle spasms—Doxorubicin—thyroid cancer	0.000248	0.00126	CcSEcCtD
Propofol—Loss of consciousness—Epirubicin—thyroid cancer	0.000245	0.00125	CcSEcCtD
Propofol—Cough—Epirubicin—thyroid cancer	0.000244	0.00124	CcSEcCtD
Propofol—Convulsion—Epirubicin—thyroid cancer	0.000242	0.00123	CcSEcCtD
Propofol—Hypertension—Epirubicin—thyroid cancer	0.000241	0.00123	CcSEcCtD
Propofol—Chest pain—Epirubicin—thyroid cancer	0.000238	0.00121	CcSEcCtD
Propofol—Myalgia—Epirubicin—thyroid cancer	0.000238	0.00121	CcSEcCtD
Propofol—CYP2E1—head—thyroid cancer	0.000238	0.0148	CbGeAlD
Propofol—Agitation—Doxorubicin—thyroid cancer	0.000237	0.00121	CcSEcCtD
Propofol—Anxiety—Epirubicin—thyroid cancer	0.000237	0.00121	CcSEcCtD
Propofol—Dry mouth—Epirubicin—thyroid cancer	0.000232	0.00118	CcSEcCtD
Propofol—Syncope—Doxorubicin—thyroid cancer	0.000232	0.00118	CcSEcCtD
Propofol—Confusional state—Epirubicin—thyroid cancer	0.00023	0.00117	CcSEcCtD
Propofol—Anaphylactic shock—Epirubicin—thyroid cancer	0.000228	0.00116	CcSEcCtD
Propofol—Oedema—Epirubicin—thyroid cancer	0.000228	0.00116	CcSEcCtD
Propofol—Loss of consciousness—Doxorubicin—thyroid cancer	0.000227	0.00116	CcSEcCtD
Propofol—Cough—Doxorubicin—thyroid cancer	0.000225	0.00115	CcSEcCtD
Propofol—Shock—Epirubicin—thyroid cancer	0.000224	0.00114	CcSEcCtD
Propofol—Convulsion—Doxorubicin—thyroid cancer	0.000224	0.00114	CcSEcCtD
Propofol—Hypertension—Doxorubicin—thyroid cancer	0.000223	0.00114	CcSEcCtD
Propofol—Tachycardia—Epirubicin—thyroid cancer	0.000222	0.00113	CcSEcCtD
Propofol—Hyperhidrosis—Epirubicin—thyroid cancer	0.00022	0.00112	CcSEcCtD
Propofol—Chest pain—Doxorubicin—thyroid cancer	0.00022	0.00112	CcSEcCtD
Propofol—Myalgia—Doxorubicin—thyroid cancer	0.00022	0.00112	CcSEcCtD
Propofol—Anxiety—Doxorubicin—thyroid cancer	0.000219	0.00112	CcSEcCtD
Propofol—Dry mouth—Doxorubicin—thyroid cancer	0.000215	0.00109	CcSEcCtD
Propofol—Hypotension—Epirubicin—thyroid cancer	0.000213	0.00108	CcSEcCtD
Propofol—Confusional state—Doxorubicin—thyroid cancer	0.000212	0.00108	CcSEcCtD
Propofol—Anaphylactic shock—Doxorubicin—thyroid cancer	0.000211	0.00107	CcSEcCtD
Propofol—Oedema—Doxorubicin—thyroid cancer	0.000211	0.00107	CcSEcCtD
Propofol—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.000208	0.00106	CcSEcCtD
Propofol—Shock—Doxorubicin—thyroid cancer	0.000207	0.00106	CcSEcCtD
Propofol—Insomnia—Epirubicin—thyroid cancer	0.000206	0.00105	CcSEcCtD
Propofol—Tachycardia—Doxorubicin—thyroid cancer	0.000206	0.00105	CcSEcCtD
Propofol—Paraesthesia—Epirubicin—thyroid cancer	0.000205	0.00104	CcSEcCtD
Propofol—Hyperhidrosis—Doxorubicin—thyroid cancer	0.000204	0.00104	CcSEcCtD
Propofol—Dyspnoea—Epirubicin—thyroid cancer	0.000203	0.00103	CcSEcCtD
Propofol—Somnolence—Epirubicin—thyroid cancer	0.000202	0.00103	CcSEcCtD
Propofol—Hypotension—Doxorubicin—thyroid cancer	0.000197	0.001	CcSEcCtD
Propofol—Fatigue—Epirubicin—thyroid cancer	0.000196	0.001	CcSEcCtD
Propofol—Pain—Epirubicin—thyroid cancer	0.000195	0.000992	CcSEcCtD
Propofol—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.000192	0.000978	CcSEcCtD
Propofol—Insomnia—Doxorubicin—thyroid cancer	0.000191	0.000971	CcSEcCtD
Propofol—Paraesthesia—Doxorubicin—thyroid cancer	0.000189	0.000964	CcSEcCtD
Propofol—CYP2D6—head—thyroid cancer	0.000188	0.0117	CbGeAlD
Propofol—Dyspnoea—Doxorubicin—thyroid cancer	0.000188	0.000957	CcSEcCtD
Propofol—Feeling abnormal—Epirubicin—thyroid cancer	0.000188	0.000956	CcSEcCtD
Propofol—Somnolence—Doxorubicin—thyroid cancer	0.000187	0.000954	CcSEcCtD
Propofol—CYP1A1—lymph node—thyroid cancer	0.000182	0.0114	CbGeAlD
Propofol—Fatigue—Doxorubicin—thyroid cancer	0.000182	0.000925	CcSEcCtD
Propofol—Urticaria—Epirubicin—thyroid cancer	0.000181	0.000921	CcSEcCtD
Propofol—Pain—Doxorubicin—thyroid cancer	0.00018	0.000918	CcSEcCtD
Propofol—Body temperature increased—Epirubicin—thyroid cancer	0.00018	0.000917	CcSEcCtD
Propofol—Abdominal pain—Epirubicin—thyroid cancer	0.00018	0.000917	CcSEcCtD
Propofol—Feeling abnormal—Doxorubicin—thyroid cancer	0.000174	0.000884	CcSEcCtD
Propofol—Urticaria—Doxorubicin—thyroid cancer	0.000167	0.000853	CcSEcCtD
Propofol—Body temperature increased—Doxorubicin—thyroid cancer	0.000167	0.000848	CcSEcCtD
Propofol—Abdominal pain—Doxorubicin—thyroid cancer	0.000167	0.000848	CcSEcCtD
Propofol—Asthenia—Epirubicin—thyroid cancer	0.000163	0.000832	CcSEcCtD
Propofol—Pruritus—Epirubicin—thyroid cancer	0.000161	0.000821	CcSEcCtD
Propofol—Diarrhoea—Epirubicin—thyroid cancer	0.000156	0.000794	CcSEcCtD
Propofol—Asthenia—Doxorubicin—thyroid cancer	0.000151	0.00077	CcSEcCtD
Propofol—Dizziness—Epirubicin—thyroid cancer	0.000151	0.000767	CcSEcCtD
Propofol—Pruritus—Doxorubicin—thyroid cancer	0.000149	0.000759	CcSEcCtD
Propofol—Vomiting—Epirubicin—thyroid cancer	0.000145	0.000737	CcSEcCtD
Propofol—Diarrhoea—Doxorubicin—thyroid cancer	0.000144	0.000734	CcSEcCtD
Propofol—Rash—Epirubicin—thyroid cancer	0.000144	0.000731	CcSEcCtD
Propofol—Dermatitis—Epirubicin—thyroid cancer	0.000143	0.000731	CcSEcCtD
Propofol—Headache—Epirubicin—thyroid cancer	0.000143	0.000727	CcSEcCtD
Propofol—Dizziness—Doxorubicin—thyroid cancer	0.000139	0.00071	CcSEcCtD
Propofol—Nausea—Epirubicin—thyroid cancer	0.000135	0.000689	CcSEcCtD
Propofol—Vomiting—Doxorubicin—thyroid cancer	0.000134	0.000682	CcSEcCtD
Propofol—Rash—Doxorubicin—thyroid cancer	0.000133	0.000677	CcSEcCtD
Propofol—Dermatitis—Doxorubicin—thyroid cancer	0.000133	0.000676	CcSEcCtD
Propofol—Headache—Doxorubicin—thyroid cancer	0.000132	0.000672	CcSEcCtD
Propofol—Nausea—Doxorubicin—thyroid cancer	0.000125	0.000637	CcSEcCtD
Propofol—GABRB3—Transmembrane transport of small molecules—RXRA—thyroid cancer	4.81e-05	0.00108	CbGpPWpGaD
Propofol—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—thyroid cancer	4.81e-05	0.00108	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—NDUFA13—thyroid cancer	4.8e-05	0.00108	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—MINPP1—thyroid cancer	4.78e-05	0.00107	CbGpPWpGaD
Propofol—UGT1A6—Metabolism—RXRA—thyroid cancer	4.76e-05	0.00107	CbGpPWpGaD
Propofol—ALB—Metabolism—MINPP1—thyroid cancer	4.75e-05	0.00107	CbGpPWpGaD
Propofol—UGT1A9—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	4.74e-05	0.00106	CbGpPWpGaD
Propofol—GABRG2—Transmembrane transport of small molecules—RXRA—thyroid cancer	4.72e-05	0.00106	CbGpPWpGaD
Propofol—GABRA1—Neuronal System—BRAF—thyroid cancer	4.72e-05	0.00106	CbGpPWpGaD
Propofol—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—thyroid cancer	4.71e-05	0.00106	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—NDUFA13—thyroid cancer	4.7e-05	0.00105	CbGpPWpGaD
Propofol—CYP1A2—Biological oxidations—RXRA—thyroid cancer	4.52e-05	0.00102	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—CHST14—thyroid cancer	4.51e-05	0.00101	CbGpPWpGaD
Propofol—CYP2A6—Metabolism—HPGD—thyroid cancer	4.51e-05	0.00101	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—NDUFA13—thyroid cancer	4.43e-05	0.000995	CbGpPWpGaD
Propofol—CYP1B1—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	4.42e-05	0.000993	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—CHST14—thyroid cancer	4.42e-05	0.000992	CbGpPWpGaD
Propofol—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—thyroid cancer	4.42e-05	0.000991	CbGpPWpGaD
Propofol—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—thyroid cancer	4.39e-05	0.000985	CbGpPWpGaD
Propofol—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—thyroid cancer	4.32e-05	0.00097	CbGpPWpGaD
Propofol—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—thyroid cancer	4.32e-05	0.000969	CbGpPWpGaD
Propofol—SCN2A—Axon guidance—HRAS—thyroid cancer	4.31e-05	0.000967	CbGpPWpGaD
Propofol—SCN4A—Axon guidance—HRAS—thyroid cancer	4.31e-05	0.000967	CbGpPWpGaD
Propofol—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—thyroid cancer	4.31e-05	0.000967	CbGpPWpGaD
Propofol—GABRB3—BDNF signaling pathway—HRAS—thyroid cancer	4.29e-05	0.000963	CbGpPWpGaD
Propofol—ALB—Hemostasis—PRKAR1A—thyroid cancer	4.27e-05	0.000958	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—MINPP1—thyroid cancer	4.27e-05	0.000957	CbGpPWpGaD
Propofol—CYP2C18—Metabolism—TPR—thyroid cancer	4.25e-05	0.000954	CbGpPWpGaD
Propofol—SCN2A—Developmental Biology—NRAS—thyroid cancer	4.2e-05	0.000943	CbGpPWpGaD
Propofol—SCN4A—Developmental Biology—NRAS—thyroid cancer	4.2e-05	0.000943	CbGpPWpGaD
Propofol—CYP2C18—Metabolism—PRKAR1A—thyroid cancer	4.18e-05	0.000938	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—CHST14—thyroid cancer	4.17e-05	0.000935	CbGpPWpGaD
Propofol—GABRA1—Transmembrane transport of small molecules—RXRA—thyroid cancer	4.13e-05	0.000926	CbGpPWpGaD
Propofol—UGT1A8—Metabolism—PPARG—thyroid cancer	4.12e-05	0.000925	CbGpPWpGaD
Propofol—ALB—Folate Metabolism—TP53—thyroid cancer	4.11e-05	0.000923	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—NDUFA13—thyroid cancer	4.06e-05	0.000912	CbGpPWpGaD
Propofol—ALB—Metabolism—NDUFA13—thyroid cancer	4.04e-05	0.000907	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—MINPP1—thyroid cancer	3.92e-05	0.00088	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—MINPP1—thyroid cancer	3.89e-05	0.000873	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—CHST14—thyroid cancer	3.82e-05	0.000857	CbGpPWpGaD
Propofol—ALB—Metabolism—CHST14—thyroid cancer	3.8e-05	0.000852	CbGpPWpGaD
Propofol—GABRB3—BDNF signaling pathway—AKT1—thyroid cancer	3.79e-05	0.00085	CbGpPWpGaD
Propofol—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—thyroid cancer	3.77e-05	0.000845	CbGpPWpGaD
Propofol—ALB—Transmembrane transport of small molecules—TPR—thyroid cancer	3.75e-05	0.000843	CbGpPWpGaD
Propofol—ALB—Transmembrane transport of small molecules—CP—thyroid cancer	3.75e-05	0.000843	CbGpPWpGaD
Propofol—ALB—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	3.69e-05	0.000829	CbGpPWpGaD
Propofol—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—thyroid cancer	3.67e-05	0.000824	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—HPGD—thyroid cancer	3.64e-05	0.000816	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—NDUFA13—thyroid cancer	3.63e-05	0.000814	CbGpPWpGaD
Propofol—SCN2A—Developmental Biology—KRAS—thyroid cancer	3.62e-05	0.000812	CbGpPWpGaD
Propofol—SCN4A—Developmental Biology—KRAS—thyroid cancer	3.62e-05	0.000812	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—HPGD—thyroid cancer	3.56e-05	0.000799	CbGpPWpGaD
Propofol—GABRB2—Transmission across Chemical Synapses—HRAS—thyroid cancer	3.54e-05	0.000795	CbGpPWpGaD
Propofol—CYP3A4—Biological oxidations—RXRA—thyroid cancer	3.49e-05	0.000783	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—CHST14—thyroid cancer	3.41e-05	0.000765	CbGpPWpGaD
Propofol—UGT1A1—Metabolism—TPR—thyroid cancer	3.36e-05	0.000754	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—HPGD—thyroid cancer	3.36e-05	0.000754	CbGpPWpGaD
Propofol—UGT1A9—Metabolism—TPR—thyroid cancer	3.36e-05	0.000754	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—NDUFA13—thyroid cancer	3.34e-05	0.000749	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—MINPP1—thyroid cancer	3.32e-05	0.000746	CbGpPWpGaD
Propofol—GABRA2—Transmission across Chemical Synapses—HRAS—thyroid cancer	3.32e-05	0.000745	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—NDUFA13—thyroid cancer	3.31e-05	0.000742	CbGpPWpGaD
Propofol—UGT1A1—Metabolism—PRKAR1A—thyroid cancer	3.3e-05	0.000742	CbGpPWpGaD
Propofol—UGT1A9—Metabolism—PRKAR1A—thyroid cancer	3.3e-05	0.000742	CbGpPWpGaD
Propofol—GABRB3—Transmission across Chemical Synapses—HRAS—thyroid cancer	3.3e-05	0.00074	CbGpPWpGaD
Propofol—UGT1A8—Metabolism—PTGS2—thyroid cancer	3.24e-05	0.000728	CbGpPWpGaD
Propofol—GABRG2—Transmission across Chemical Synapses—HRAS—thyroid cancer	3.24e-05	0.000727	CbGpPWpGaD
Propofol—CYP2C18—Metabolism—SLC5A5—thyroid cancer	3.18e-05	0.000714	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—CHST14—thyroid cancer	3.14e-05	0.000704	CbGpPWpGaD
Propofol—CYP1B1—Metabolism—TPR—thyroid cancer	3.13e-05	0.000703	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—CHST14—thyroid cancer	3.11e-05	0.000698	CbGpPWpGaD
Propofol—CYP1B1—Metabolism—PRKAR1A—thyroid cancer	3.08e-05	0.000692	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—HPGD—thyroid cancer	3.08e-05	0.000691	CbGpPWpGaD
Propofol—SCN2A—Developmental Biology—HRAS—thyroid cancer	3.07e-05	0.00069	CbGpPWpGaD
Propofol—SCN4A—Developmental Biology—HRAS—thyroid cancer	3.07e-05	0.00069	CbGpPWpGaD
Propofol—ALB—Metabolism—HPGD—thyroid cancer	3.06e-05	0.000687	CbGpPWpGaD
Propofol—UGT1A6—Metabolism—PPARG—thyroid cancer	3.01e-05	0.000675	CbGpPWpGaD
Propofol—UGT1A9—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	2.99e-05	0.000672	CbGpPWpGaD
Propofol—GABRA1—Transmission across Chemical Synapses—HRAS—thyroid cancer	2.83e-05	0.000635	CbGpPWpGaD
Propofol—UGT1A8—Metabolism—PTEN—thyroid cancer	2.83e-05	0.000635	CbGpPWpGaD
Propofol—ALB—Hemostasis—IFNA2—thyroid cancer	2.83e-05	0.000634	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—NDUFA13—thyroid cancer	2.83e-05	0.000634	CbGpPWpGaD
Propofol—ALB—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	2.81e-05	0.000631	CbGpPWpGaD
Propofol—CYP1B1—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	2.79e-05	0.000627	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—HPGD—thyroid cancer	2.75e-05	0.000617	CbGpPWpGaD
Propofol—CYP1A1—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	2.72e-05	0.000611	CbGpPWpGaD
Propofol—SCN2A—Developmental Biology—AKT1—thyroid cancer	2.72e-05	0.000609	CbGpPWpGaD
Propofol—SCN4A—Developmental Biology—AKT1—thyroid cancer	2.72e-05	0.000609	CbGpPWpGaD
Propofol—GABRB2—Neuronal System—HRAS—thyroid cancer	2.71e-05	0.000609	CbGpPWpGaD
Propofol—CYP2C18—Metabolism—RXRA—thyroid cancer	2.67e-05	0.0006	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—CHST14—thyroid cancer	2.66e-05	0.000596	CbGpPWpGaD
Propofol—CYP2A6—Metabolism—TPR—thyroid cancer	2.59e-05	0.000581	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—MINPP1—thyroid cancer	2.56e-05	0.000576	CbGpPWpGaD
Propofol—CYP2A6—Metabolism—PRKAR1A—thyroid cancer	2.55e-05	0.000572	CbGpPWpGaD
Propofol—GABRA2—Neuronal System—HRAS—thyroid cancer	2.54e-05	0.000571	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—HPGD—thyroid cancer	2.53e-05	0.000567	CbGpPWpGaD
Propofol—GABRB3—Neuronal System—HRAS—thyroid cancer	2.53e-05	0.000567	CbGpPWpGaD
Propofol—UGT1A1—Metabolism—SLC5A5—thyroid cancer	2.51e-05	0.000564	CbGpPWpGaD
Propofol—UGT1A9—Metabolism—SLC5A5—thyroid cancer	2.51e-05	0.000564	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—HPGD—thyroid cancer	2.51e-05	0.000562	CbGpPWpGaD
Propofol—CYP2C8—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	2.5e-05	0.000561	CbGpPWpGaD
Propofol—ALB—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	2.48e-05	0.000557	CbGpPWpGaD
Propofol—GABRG2—Neuronal System—HRAS—thyroid cancer	2.48e-05	0.000557	CbGpPWpGaD
Propofol—UGT1A6—Metabolism—PTGS2—thyroid cancer	2.37e-05	0.000531	CbGpPWpGaD
Propofol—ALB—Transmembrane transport of small molecules—RXRA—thyroid cancer	2.36e-05	0.00053	CbGpPWpGaD
Propofol—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	2.36e-05	0.000529	CbGpPWpGaD
Propofol—CYP1B1—Metabolism—SLC5A5—thyroid cancer	2.34e-05	0.000526	CbGpPWpGaD
Propofol—CYP2C19—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	2.23e-05	0.0005	CbGpPWpGaD
Propofol—CYP1B1—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	2.2e-05	0.000493	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—NDUFA13—thyroid cancer	2.18e-05	0.000489	CbGpPWpGaD
Propofol—GABRA1—Neuronal System—HRAS—thyroid cancer	2.17e-05	0.000487	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—HPGD—thyroid cancer	2.14e-05	0.000481	CbGpPWpGaD
Propofol—UGT1A1—Metabolism—RXRA—thyroid cancer	2.11e-05	0.000474	CbGpPWpGaD
Propofol—UGT1A9—Metabolism—RXRA—thyroid cancer	2.11e-05	0.000474	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—TPR—thyroid cancer	2.09e-05	0.000469	CbGpPWpGaD
Propofol—UGT1A6—Metabolism—PTEN—thyroid cancer	2.06e-05	0.000463	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—PRKAR1A—thyroid cancer	2.06e-05	0.000461	CbGpPWpGaD
Propofol—UGT1A9—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	2.05e-05	0.000461	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—CHST14—thyroid cancer	2.05e-05	0.00046	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—TPR—thyroid cancer	2.05e-05	0.000459	CbGpPWpGaD
Propofol—CYP2C9—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	2.03e-05	0.000456	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—PRKAR1A—thyroid cancer	2.01e-05	0.000452	CbGpPWpGaD
Propofol—CYP1B1—Metabolism—RXRA—thyroid cancer	1.97e-05	0.000442	CbGpPWpGaD
Propofol—CYP2A6—Metabolism—SLC5A5—thyroid cancer	1.94e-05	0.000435	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—TPR—thyroid cancer	1.93e-05	0.000433	CbGpPWpGaD
Propofol—CYP1B1—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.92e-05	0.00043	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—PRKAR1A—thyroid cancer	1.9e-05	0.000426	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—TPR—thyroid cancer	1.77e-05	0.000397	CbGpPWpGaD
Propofol—ALB—Metabolism—TPR—thyroid cancer	1.76e-05	0.000395	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—PRKAR1A—thyroid cancer	1.74e-05	0.00039	CbGpPWpGaD
Propofol—CYP1A2—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	1.74e-05	0.00039	CbGpPWpGaD
Propofol—ALB—Metabolism—PRKAR1A—thyroid cancer	1.73e-05	0.000388	CbGpPWpGaD
Propofol—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.72e-05	0.000386	CbGpPWpGaD
Propofol—CYP2C18—Metabolism—PPARG—thyroid cancer	1.69e-05	0.000379	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—HPGD—thyroid cancer	1.65e-05	0.000371	CbGpPWpGaD
Propofol—UGT1A8—Metabolism—AKT1—thyroid cancer	1.63e-05	0.000366	CbGpPWpGaD
Propofol—CYP2A6—Metabolism—RXRA—thyroid cancer	1.63e-05	0.000365	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—TPR—thyroid cancer	1.58e-05	0.000354	CbGpPWpGaD
Propofol—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.58e-05	0.000354	CbGpPWpGaD
Propofol—ALB—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.57e-05	0.000352	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—SLC5A5—thyroid cancer	1.56e-05	0.000351	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—PRKAR1A—thyroid cancer	1.55e-05	0.000349	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—SLC5A5—thyroid cancer	1.53e-05	0.000344	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—TPR—thyroid cancer	1.45e-05	0.000326	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—SLC5A5—thyroid cancer	1.44e-05	0.000324	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—TPR—thyroid cancer	1.44e-05	0.000323	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—PRKAR1A—thyroid cancer	1.43e-05	0.000321	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—PRKAR1A—thyroid cancer	1.42e-05	0.000318	CbGpPWpGaD
Propofol—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.41e-05	0.000316	CbGpPWpGaD
Propofol—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.35e-05	0.000304	CbGpPWpGaD
Propofol—UGT1A1—Metabolism—PPARG—thyroid cancer	1.33e-05	0.000299	CbGpPWpGaD
Propofol—UGT1A9—Metabolism—PPARG—thyroid cancer	1.33e-05	0.000299	CbGpPWpGaD
Propofol—CYP2C18—Metabolism—PTGS2—thyroid cancer	1.33e-05	0.000298	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—SLC5A5—thyroid cancer	1.32e-05	0.000297	CbGpPWpGaD
Propofol—ALB—Platelet activation, signaling and aggregation—AKT1—thyroid cancer	1.32e-05	0.000296	CbGpPWpGaD
Propofol—ALB—Metabolism—SLC5A5—thyroid cancer	1.32e-05	0.000295	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—RXRA—thyroid cancer	1.31e-05	0.000295	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—RXRA—thyroid cancer	1.29e-05	0.000289	CbGpPWpGaD
Propofol—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.28e-05	0.000288	CbGpPWpGaD
Propofol—CYP1B1—Metabolism—PPARG—thyroid cancer	1.24e-05	0.000279	CbGpPWpGaD
Propofol—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.24e-05	0.000278	CbGpPWpGaD
Propofol—ALB—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.23e-05	0.000277	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—TPR—thyroid cancer	1.23e-05	0.000276	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—RXRA—thyroid cancer	1.21e-05	0.000272	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—PRKAR1A—thyroid cancer	1.21e-05	0.000272	CbGpPWpGaD
Propofol—UGT1A6—Metabolism—AKT1—thyroid cancer	1.19e-05	0.000267	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—SLC5A5—thyroid cancer	1.18e-05	0.000265	CbGpPWpGaD
Propofol—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.18e-05	0.000265	CbGpPWpGaD
Propofol—CYP2C18—Metabolism—PTEN—thyroid cancer	1.16e-05	0.00026	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—RXRA—thyroid cancer	1.11e-05	0.00025	CbGpPWpGaD
Propofol—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.11e-05	0.000248	CbGpPWpGaD
Propofol—ALB—Metabolism—RXRA—thyroid cancer	1.11e-05	0.000248	CbGpPWpGaD
Propofol—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.1e-05	0.000246	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—SLC5A5—thyroid cancer	1.09e-05	0.000244	CbGpPWpGaD
Propofol—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.08e-05	0.000243	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—SLC5A5—thyroid cancer	1.08e-05	0.000242	CbGpPWpGaD
Propofol—ALB—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.08e-05	0.000241	CbGpPWpGaD
Propofol—ALB—Hemostasis—NRAS—thyroid cancer	1.05e-05	0.000237	CbGpPWpGaD
Propofol—UGT1A1—Metabolism—PTGS2—thyroid cancer	1.05e-05	0.000235	CbGpPWpGaD
Propofol—UGT1A9—Metabolism—PTGS2—thyroid cancer	1.05e-05	0.000235	CbGpPWpGaD
Propofol—CYP2A6—Metabolism—PPARG—thyroid cancer	1.03e-05	0.000231	CbGpPWpGaD
Propofol—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.01e-05	0.000227	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—RXRA—thyroid cancer	9.93e-06	0.000223	CbGpPWpGaD
Propofol—CYP1B1—Metabolism—PTGS2—thyroid cancer	9.79e-06	0.00022	CbGpPWpGaD
Propofol—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	9.66e-06	0.000217	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—TPR—thyroid cancer	9.49e-06	0.000213	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—PRKAR1A—thyroid cancer	9.34e-06	0.00021	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—SLC5A5—thyroid cancer	9.21e-06	0.000207	CbGpPWpGaD
Propofol—UGT1A1—Metabolism—PTEN—thyroid cancer	9.15e-06	0.000205	CbGpPWpGaD
Propofol—UGT1A9—Metabolism—PTEN—thyroid cancer	9.15e-06	0.000205	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—RXRA—thyroid cancer	9.13e-06	0.000205	CbGpPWpGaD
Propofol—ALB—Hemostasis—KRAS—thyroid cancer	9.07e-06	0.000204	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—RXRA—thyroid cancer	9.05e-06	0.000203	CbGpPWpGaD
Propofol—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	8.81e-06	0.000198	CbGpPWpGaD
Propofol—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	8.63e-06	0.000194	CbGpPWpGaD
Propofol—CYP1B1—Metabolism—PTEN—thyroid cancer	8.53e-06	0.000192	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—PPARG—thyroid cancer	8.3e-06	0.000186	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—PPARG—thyroid cancer	8.13e-06	0.000182	CbGpPWpGaD
Propofol—CYP2A6—Metabolism—PTGS2—thyroid cancer	8.09e-06	0.000182	CbGpPWpGaD
Propofol—ALB—Hemostasis—TP53—thyroid cancer	8.06e-06	0.000181	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—RXRA—thyroid cancer	7.74e-06	0.000174	CbGpPWpGaD
Propofol—ALB—Hemostasis—HRAS—thyroid cancer	7.71e-06	0.000173	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—PPARG—thyroid cancer	7.66e-06	0.000172	CbGpPWpGaD
Propofol—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	7.52e-06	0.000169	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—SLC5A5—thyroid cancer	7.11e-06	0.000159	CbGpPWpGaD
Propofol—CYP2A6—Metabolism—PTEN—thyroid cancer	7.05e-06	0.000158	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—PPARG—thyroid cancer	7.02e-06	0.000158	CbGpPWpGaD
Propofol—ALB—Metabolism—PPARG—thyroid cancer	6.98e-06	0.000157	CbGpPWpGaD
Propofol—ALB—Hemostasis—AKT1—thyroid cancer	6.81e-06	0.000153	CbGpPWpGaD
Propofol—CYP2C18—Metabolism—AKT1—thyroid cancer	6.67e-06	0.00015	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—PTGS2—thyroid cancer	6.53e-06	0.000146	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—PTGS2—thyroid cancer	6.39e-06	0.000143	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—PPARG—thyroid cancer	6.27e-06	0.000141	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—PTGS2—thyroid cancer	6.03e-06	0.000135	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—RXRA—thyroid cancer	5.97e-06	0.000134	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—PPARG—thyroid cancer	5.77e-06	0.000129	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—PPARG—thyroid cancer	5.72e-06	0.000128	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—PTEN—thyroid cancer	5.69e-06	0.000128	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—PTEN—thyroid cancer	5.57e-06	0.000125	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—PTGS2—thyroid cancer	5.52e-06	0.000124	CbGpPWpGaD
Propofol—ALB—Metabolism—PTGS2—thyroid cancer	5.49e-06	0.000123	CbGpPWpGaD
Propofol—UGT1A1—Metabolism—AKT1—thyroid cancer	5.27e-06	0.000118	CbGpPWpGaD
Propofol—UGT1A9—Metabolism—AKT1—thyroid cancer	5.27e-06	0.000118	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—PTEN—thyroid cancer	5.26e-06	0.000118	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—PTGS2—thyroid cancer	4.93e-06	0.000111	CbGpPWpGaD
Propofol—CYP1B1—Metabolism—AKT1—thyroid cancer	4.92e-06	0.00011	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—PPARG—thyroid cancer	4.88e-06	0.00011	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—PTEN—thyroid cancer	4.82e-06	0.000108	CbGpPWpGaD
Propofol—ALB—Metabolism—PTEN—thyroid cancer	4.79e-06	0.000108	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—PTGS2—thyroid cancer	4.54e-06	0.000102	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—PTGS2—thyroid cancer	4.5e-06	0.000101	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—PTEN—thyroid cancer	4.3e-06	9.65e-05	CbGpPWpGaD
Propofol—CYP2A6—Metabolism—AKT1—thyroid cancer	4.07e-06	9.12e-05	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—PTEN—thyroid cancer	3.96e-06	8.88e-05	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—PTEN—thyroid cancer	3.92e-06	8.8e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—PTGS2—thyroid cancer	3.84e-06	8.62e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—PPARG—thyroid cancer	3.77e-06	8.46e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—PTEN—thyroid cancer	3.35e-06	7.52e-05	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—AKT1—thyroid cancer	3.28e-06	7.36e-05	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—AKT1—thyroid cancer	3.21e-06	7.21e-05	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—AKT1—thyroid cancer	3.03e-06	6.8e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—PTGS2—thyroid cancer	2.97e-06	6.66e-05	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—AKT1—thyroid cancer	2.78e-06	6.23e-05	CbGpPWpGaD
Propofol—ALB—Metabolism—AKT1—thyroid cancer	2.76e-06	6.2e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—PTEN—thyroid cancer	2.59e-06	5.8e-05	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—AKT1—thyroid cancer	2.48e-06	5.56e-05	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—AKT1—thyroid cancer	2.28e-06	5.12e-05	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—AKT1—thyroid cancer	2.26e-06	5.07e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—AKT1—thyroid cancer	1.93e-06	4.33e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—AKT1—thyroid cancer	1.49e-06	3.34e-05	CbGpPWpGaD
